Cancer clinical trials in the region Pays de la Loire

246 currently recruiting clinical trials
Region Pays de la Loire

Early Access Endometrial cancer
Stage III Stage IV Locally Advanced Metastatic MSS/pMMR None 1
MSI/dMMR
GlaxoSmithKline
Early Access Bladder / Urinary Tract / Urethral cancer
Invasive bladder cancer Urothelial carcinoma Locally Advanced Metastatic None Systemic Treatment-Naive
Merck Sharp & Dohme LLC
Early Access Stomach and esophageal cancer
Stomach Oesogastric junction Adenocarcinoma Locally Advanced Metastatic HER2 PDL1 Positive (1% <= X < 25%) PDL1 Positive (25% <= X < 50%) PDL1 Positive (>= 50%) None Systemic Treatment-Naive
Merck Sharp & Dohme LLC
Early Access Bladder / Urinary Tract / Urethral cancer
Invasive bladder cancer Urothelial carcinoma Locally Advanced Metastatic None Systemic Treatment-Naive
Astellas Pharma Développement mondial, Inc.
Early Access Kidney cancer Pancreas cancer
Clear cell carcinoma Neuroendocrine tumor Localized Von Hippel-Lindau syndrome (VHL)
Merck Sharp & Dohme LLC
Early Access Endometrial cancer
Stage III Stage IV Locally Advanced Metastatic MSI/dMMR None 1
GlaxoSmithKline
Early Access Stomach and esophageal cancer
Stomach Oesogastric junction Adenocarcinoma Locally Advanced Metastatic Claudin 18.2 PDL1 Negative (< 1%) None Systemic Treatment-Naive
HER2
Astellas Pharma Développement mondial, Inc.
Early Access Liver and bile duct cancer
Intrahepatic cholangiocarcinoma Extrahepatic cholangiocarcinoma Locally Advanced Metastatic HER2 1 2 3 or more Chemotherapy
Systemic Treatment-Naive
Jazz Pharmaceuticals
Early Access Lung cancer
NSCLC (Non-Small Cell Lung Cancer) Non-squamous NSCLC Locally Advanced EGFR None Chemotherapy Radiotherapy
AstraZeneca
Early Access Lymphoma
B cell lymphoma Large B cell lymphoma 2 3 or more
Systemic Treatment-Naive
Abbvie